Fundz

Select Ion, Inc. reported raising $5.06 Million in an initial SEC Form D filing, from an offering of $5.06 Million

PRIVATEApr 08, 2021

Amount Raised

$5.06 Million

$5.06 Million sold, per SEC Form D (first sale Apr 8, 2021)

Round Type

Venture

San DiegoBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as selectIon that raised within 45 days of this round, from Fundz verified event records.

  • Numab Therapeutics raised an undisclosed amount (Series C) on May 20, 2021.
  • Immunome Inc. raised an undisclosed amount (Grant) on May 20, 2021.
  • Haya Therapeutics raised an undisclosed amount (Seed) on May 20, 2021.
  • Allied BioScience, Inc. raised $250K on May 19, 2021.
  • MAIA Biotechnology raised $8M (Funding Round) on May 19, 2021.
  • PROXIMITY THERAPEUTICS, INC. raised $2M (Seed) on May 19, 2021.

Who to call at selectIon, and when

A new round usually means selectIon is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day selectIon raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at selectIon, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at selectIon. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

selectIon

Location

655 India Street

San Diego, California, United States

About

selectION has established an efficient technology platform to develop highly selective peptide blockers for ion channels. Their most advanced drug candidate is si-544 which is a best-in-class Kv1.3 blocker for treatment of effector memory T cell (TEM) driven diseases. The company is well positioned to expand its range of class-leading ion channelblockers by targeting additional potassium, sodium, calcium and chloride channels, which will lead to other clinical applications in pain management and oncology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment selectIon raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts11 people are listed at selectIon. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for selectIon's next move

See what Strategic adds

selectIon raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.